Todd Giorgio
-
Nanoparticles boost anti-cancer immunity
by Bill Snyder The growth of epithelial ovarian cancer, one of the most lethal malignancies, is associated with the presence of tumor-associated macrophages (TAMs), white blood cells that can block the anti-cancer activity of the immune system and immunotherapy. Fortunately, TAMs can be “repolarized,” converted from immunosuppressive tumor-promoters to inflammatory tumor-fighters. Now, Associate Professor of Pharmacology Fiona Yull,... Read MoreAug 16, 2022
-
Three engineering faculty win Vanderbilt grants to support early-stage pioneering research
Three engineering faculty members have received grants to support the early stages of pioneering research projects identified as likely candidates for further funding from federal, foundation and industry sponsors. Spring 2022 Seeding Success Grants were awarded to 14 faculty and are the second cycle of the internal early investment funding initiative. The grants, awarded to faculty spanning the... Read MoreJun 29, 2022
-
Micelle “packets” deliver cancer drugs
Vanderbilt researchers designed micelle “packets” to selectively deliver anti-cancer drugs to breast cancer cells. Read MoreApr 8, 2015
-
Vanderbilt startup BioNanovations gets accelerated
Vanderbilt graduate student Charleson Bell, who is the president of the high tech startup BioNanovations, is participating in a 12-week accelerator program in Silicon Valley specifically designed to encourage underrepresented tech entrepeneurs. Read MoreAug 30, 2013